对照选择与混杂因素:日本一项病例对照研究评价无细胞百日咳疫苗效果的经验
该报告基于一项评价无细胞百日咳疫苗(DTaP)效果的病例对照研究,纳入新诊断百日咳病例及按年龄和性别匹配的朋友对照,比较两组DTaP接种史。调整潜在混杂因素后,四剂DTaP接种对儿科医生诊断百日咳的OR=0.11(95%CI 0.01-0.99),对实验室确诊百日咳的OR=0.07(95%CI 0.01-0.82)。有类固醇治疗史者(OR=5.67)和近期与持续咳嗽者接触者(OR=4.12)与百日咳呈正相关。
要点
- 四剂DTaP接种与儿科医生诊断百日咳的OR=0.11(95%CI 0.01-0.99)。
- 四剂DTaP接种与实验室确诊百日咳的OR=0.07(95%CI 0.01-0.82)。
- 类固醇治疗史(OR=5.67)和近期接触持续咳嗽者(OR=4.12)与百日咳正相关。
核心结论
- 使用病例对照研究评价疫苗效果时,朋友对照可能最优,因其与病例有相似的病原体暴露经历。
- 为尽可能准确评估疫苗效果,应通过匹配或分析技术充分控制混杂效应。
研究设计与样本
- 病例对照研究,纳入新诊断百日咳病例及按年龄和性别匹配的朋友对照。
- 比较两组DTaP疫苗接种史,采用逻辑回归模型计算接种对百日咳发生的OR及95%CI。
主要发现
- 调整潜在混杂因素后,四剂DTaP接种对儿科医生诊断百日咳的OR=0.11(95%CI 0.01-0.99)。
- 四剂DTaP接种对实验室确诊百日咳的OR=0.07(95%CI 0.01-0.82)。
- 有类固醇治疗史者与百日咳正相关(OR=5.67)。
- 近期与持续咳嗽者接触者与百日咳正相关(OR=4.12)。
临床怎么用
- 作者认为,使用病例对照研究评价疫苗效果时,朋友对照可能最优。
- 作者认为,应通过匹配或分析技术充分控制混杂效应以尽可能准确评估疫苗效果。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
When using a case-control study design to examine vaccine effectiveness, both the selection of control subjects and the consideration of potential confounders must be the important issues to ensure accurate results. In this report, we described our experience from a case-control study conducted to evaluate the effectiveness of acellular pertussis vaccine combined with diphtheria-tetanus toxoids (DTaP vaccine). Newly diagnosed pertussis cases and age- and sex-matched friend-controls were enrolled, and the history of DTaP vaccination was compared between groups. Logistic regression models were used to calculate odds ratios (ORs) and 95% confidence intervals (CIs) of vaccination for development of pertussis. After adjustment for potential confounders, four doses of DTaP vaccination showed a lower OR for pediatrician-diagnosed pertussis (OR=0.11, 95% CI, 0.01-0.99). In addition, the decreasing OR of four doses vaccination was more pronounced for laboratory-confirmed pertussis (OR=0.07, 95%CI, 0.01-0.82). Besides, positive association with pertussis was observed in subjects with a history of steroid treatment (OR=5.67) and those with a recent contact with a lasting cough (OR=4.12). When using a case-control study to evaluate the effectiveness of vaccines, particularly those for uncommon infectious diseases such as pertussis, the use of friend-controls may be optimal due to the fact that they shared a similar experience for exposure to the pathogen as the cases. In addition, to assess vaccine effectiveness as accurately as possible, the effects of confounding should be adequately controlled with a matching or analysis technique.
引用
- Ohfuji S, Okada K, Nakano T, et al. Control selection and confounding factors: A lesson from a Japanese case-control study to examine acellular pertussis vaccine effectiveness. Vaccine. 2017. PMID: 28818472. doi:10.1016/j.vaccine.2017.07.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。